Treatment of Primary Epithelial Ovarian Cancer Abstract

Victoria YK CHAI1, Carmen KM CHOI2, Mandy MY CHU3, KY TSE3
1 Department of Obstetrics and Gynaecology, United Christian Hospital
2 Department of Obstetrics and Gynaecology, Pamela Youde Nethersole Eastern Hospital
3 Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong
Maximal cytoreduction and platinum-based chemotherapy remain the mainstay treatments for epithelial ovarian cancer. New modalities include targeted therapy, intraperitoneal chemotherapy, and hyperthermic intraperitoneal chemotherapy. With different characteristics in different patients and the complexity of diseases, treatment should be individualised and reviewed by a multidisciplinary team.
Hong Kong J Gynaecol Obstet Midwifery 2018; 18(2):110–6
  Copyright © 2022 by the Obstetrical & Gynaecological Society of Hong Kong
  and the Hong Kong Midwives Association
  Print ISSN:1608-9367
  Online ISSN:2225-904X
  This website is developed and maintained by
  the HKAM Press